Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 6/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5747124 | 0.98 | CYP3A4 (0.40) | KDM4EGAAMAPTCYP3A4ALDH1A1 | |
| SCHEMBL676864 | 0.92 | KDM4E (0.41) | KDM4EGAAMAPTCYP3A4ALDH1A1 | |
| Hydrochloric Acid SCHEMBL5746772 | 0.90 | MAPT (0.40) | KDM4EGAAMAPTCYP3A4ALDH1A1 | |
| SCHEMBL13967975 | 0.85 | SIGMAR1 (0.45) | CYP3A4ALDH1A1HPGDHSD17B10CYP1A2 | |
| SCHEMBL13967926 | 0.85 | KDM4E (0.34) | KDM4EGAAMAPTCYP3A4ALDH1A1 | |
| SCHEMBL13967982 | 0.84 | KDM4E (0.33) | KDM4EGAAMAPTSIGMAR1 | |
| SCHEMBL13967904 | 0.79 | KDM4E (0.32) | KDM4EGAAMAPTSIGMAR1 | |
| SCHEMBL16376115 | 0.79 | HTR2A (0.34) | KDM4EGAAMAPTSIGMAR1HTR2A | |
| SCHEMBL13967928 | 0.79 | KDM4E (0.32) | KDM4EGAAMAPTSIGMAR1 | |
| SCHEMBL13967970 | 0.79 | SIGMAR1 (0.33) | KDM4EGAAMAPTALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060269498-A1 | Hair shaping composition comprising at least one polyguanidine other than hydroxide | L'OREAL S.A. (FR) | 2006-11-30 | — | — | US | claimed |
| EP-1723946-A1 | Composition for straightening the hair comprising at least one multi-guanidine not being a hydroxide | L'OREAL (FR) | 2006-11-22 | — | — | EP | claimed |
| EP-1723947-A1 | Hair waving composition comprising at least a multiguanidine | L'OREAL (FR) | 2006-11-22 | — | — | EP | claimed |
| US-20060269498-A1 | Hair shaping composition comprising at least one polyguanidine other than hydroxide | L'OREAL S.A. (FR) | 2006-11-30 | — | — | US | disclosed |
| EP-1723946-A1 | Composition for straightening the hair comprising at least one multi-guanidine not being a hydroxide | L'OREAL (FR) | 2006-11-22 | — | — | EP | disclosed |
| EP-1723947-A1 | Hair waving composition comprising at least a multiguanidine | L'OREAL (FR) | 2006-11-22 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060269498-A1 | Hair shaping composition comprising at least one polyguanidine other than hydroxide | KRT18, PLOD3, PRKDC | KDM4E 440/4885GAA 1412/4885MAPT 1418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.